These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24626819)

  • 1. Omega-3 fatty acid supplementation during pregnancy and respiratory symptoms in children.
    Escamilla-Nuñez MC; Barraza-Villarreal A; Hernández-Cadena L; Navarro-Olivos E; Sly PD; Romieu I
    Chest; 2014 Aug; 146(2):373-382. PubMed ID: 24626819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico.
    Ramakrishnan U; Stein AD; Parra-Cabrera S; Wang M; Imhoff-Kunsch B; Juárez-Márquez S; Rivera J; Martorell R
    Food Nutr Bull; 2010 Jun; 31(2 Suppl):S108-16. PubMed ID: 20715595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review.
    Newberry SJ; Chung M; Booth M; Maglione MA; Tang AM; O'Hanlon CE; Wang DD; Okunogbe A; Huang C; Motala A; Trimmer M; Dudley W; Shanman R; Coker TR; Shekelle PG
    Evid Rep Technol Assess (Full Rep); 2016 Oct; (224):1-826. PubMed ID: 30307735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Kansas University DHA Outcomes Study (KUDOS) clinical trial: long-term behavioral follow-up of the effects of prenatal DHA supplementation.
    Colombo J; Shaddy DJ; Gustafson K; Gajewski BJ; Thodosoff JM; Kerling E; Carlson SE
    Am J Clin Nutr; 2019 May; 109(5):1380-1392. PubMed ID: 31004139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acid addition during pregnancy.
    Middleton P; Gomersall JC; Gould JF; Shepherd E; Olsen SF; Makrides M
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003402. PubMed ID: 30480773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of DocosaHexaenoic Acid supplementation during pregnancy and lactation on Neurodevelopment of the offspring in India (DHANI): trial protocol.
    Khandelwal S; Swamy MK; Patil K; Kondal D; Chaudhry M; Gupta R; Divan G; Kamate M; Ramakrishnan L; Bellad MB; Gan A; Kodkany BS; Martorell R; Srinath Reddy K; Prabhakaran D; Ramakrishnan U; Tandon N; Stein AD
    BMC Pediatr; 2018 Aug; 18(1):261. PubMed ID: 30077178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery.
    Makrides M; Best K; Yelland L; McPhee A; Zhou S; Quinlivan J; Dodd J; Atkinson E; Safa H; van Dam J; Khot N; Dekker G; Skubisz M; Anderson A; Kean B; Bowman A; McCallum C; Cashman K; Gibson R
    N Engl J Med; 2019 Sep; 381(11):1035-1045. PubMed ID: 31509674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic disease in infants up to 2 years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation.
    Furuhjelm C; Warstedt K; Fagerås M; Fälth-Magnusson K; Larsson J; Fredriksson M; Duchén K
    Pediatr Allergy Immunol; 2011 Aug; 22(5):505-14. PubMed ID: 21332799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal prenatal and/or postnatal n-3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood.
    Gunaratne AW; Makrides M; Collins CT
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010085. PubMed ID: 26197477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol.
    Carlson SE; Gajewski BJ; Valentine CJ; Rogers LK; Weiner CP; DeFranco EA; Buhimschi CS
    BMC Pregnancy Childbirth; 2017 Feb; 17(1):62. PubMed ID: 28193189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Probiotics in Pregnancy Study (PiP Study): rationale and design of a double-blind randomised controlled trial to improve maternal health during pregnancy and prevent infant eczema and allergy.
    Barthow C; Wickens K; Stanley T; Mitchell EA; Maude R; Abels P; Purdie G; Murphy R; Stone P; Kang J; Hood F; Rowden J; Barnes P; Fitzharris P; Craig J; Slykerman RF; Crane J
    BMC Pregnancy Childbirth; 2016 Jun; 16(1):133. PubMed ID: 27255079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine distribution in mothers and breastfed children after omega-3 LCPUFAs supplementation during the last trimester of pregnancy and the lactation period: A randomized, controlled trial.
    Rodriguez-Santana Y; Ochoa JJ; Lara-Villoslada F; Kajarabille N; Saavedra-Santana P; Hurtado JA; Peña M; Diaz-Castro J; Sebastian-Garcia I; Machin-Martin E; Villanueva M; Ramirez-Garcia O; Peña-Quintana L
    Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():32-38. PubMed ID: 29031393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DHA supplementation and pregnancy outcomes.
    Carlson SE; Colombo J; Gajewski BJ; Gustafson KM; Mundy D; Yeast J; Georgieff MK; Markley LA; Kerling EH; Shaddy DJ
    Am J Clin Nutr; 2013 Apr; 97(4):808-15. PubMed ID: 23426033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal docosahexaenoic acid supplementation and infant morbidity: randomized controlled trial.
    Imhoff-Kunsch B; Stein AD; Martorell R; Parra-Cabrera S; Romieu I; Ramakrishnan U
    Pediatrics; 2011 Sep; 128(3):e505-12. PubMed ID: 21807696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of prenatal docosahexaenoic acid supplementation on infant outcomes in African American women living in low-income environments: A randomized, controlled trial.
    Keenan K; Hipwell A; McAloon R; Hoffmann A; Mohanty A; Magee K
    Psychoneuroendocrinology; 2016 Sep; 71():170-5. PubMed ID: 27290652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol for a randomised controlled trial evaluating the effect of prenatal omega-3 LCPUFA supplementation to reduce the incidence of preterm birth: the ORIP trial.
    Zhou SJ; Best K; Gibson R; McPhee A; Yelland L; Quinlivan J; Makrides M
    BMJ Open; 2017 Sep; 7(9):e018360. PubMed ID: 28947468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prenatal docosahexaenoic acid supplementation on offspring cardiometabolic health at 11 years differs by maternal single nucleotide polymorphism rs174602: follow-up of a randomized controlled trial in Mexico.
    Wimalasena ST; Ramírez-Silva CI; Gonzalez Casanova I; Stein AD; Sun YV; Rivera JA; Demmelmair H; Koletzko B; Ramakrishnan U
    Am J Clin Nutr; 2023 Dec; 118(6):1123-1132. PubMed ID: 37839707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of DNA methylation states and infant immune system by dietary supplementation with ω-3 PUFA during pregnancy in an intervention study.
    Lee HS; Barraza-Villarreal A; Hernandez-Vargas H; Sly PD; Biessy C; Ramakrishnan U; Romieu I; Herceg Z
    Am J Clin Nutr; 2013 Aug; 98(2):480-7. PubMed ID: 23761484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal Maternal Docosahexaenoic Acid (DHA) Supplementation and Newborn Anthropometry in India: Findings from DHANI.
    Khandelwal S; Kondal D; Chaudhry M; Patil K; Swamy MK; Pujeri G; Mane SB; Kudachi Y; Gupta R; Ramakrishnan U; Stein AD; Prabhakaran D; Tandon N
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33668849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.